Showing results (91-100 of 169) with videos related to

Sort By:
Pageof 17
Focus (American Psychiatric Publishing)|December 21, 2020
The Neurobiology of Treatment-Resistant Schizophrenia: Paths to Antipsychotic Resistance and A Roadmap for Future ResearchSteven G Potkin, John M Kane, Christoph U Correll, et al.
NPJ Schizophrenia|January 9, 2020
The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future researchSteven G Potkin, John M Kane, Christoph U Correll, et al.
The Journal of Clinical Psychiatry|May 17, 2007
Aripiprazole effects in patients with acute schizophrenia experiencing higher or lower agitation: a post hoc analysis of 4 randomized, placebo-controlled clinical trialsStephen R Marder, Britt West, Gina S Lau, et al.
Schizophrenia Research|September 11, 2024
Efficacy of KarXT on negative symptoms in acute schizophrenia: A post hoc analysis of pooled data from 3 trialsWilliam P Horan, Steven D Targum, Amy Claxton, et al.
The Journal of Clinical Psychiatry|December 17, 2025
Psychosocial Interventions and Functional Recovery in Schizophrenia-Realizing Opportunities TodayRajiv Tandon, Deanna M Barch, Robert W Buchanan, et al.
The American Journal of Psychiatry|September 28, 2007
Social cognition [corrected] and neurocognition: effects of risperidone, olanzapine, and haloperidolMark J Sergi, Michael F Green, Clifford Widmark, et al.
The Journal of Clinical Psychiatry|January 17, 2012
Mid-term and long-term efficacy and effectiveness of antipsychotic medications for schizophrenia: a data-driven, personalized clinical approachIra D Glick, Christoph U Correll, A Carlo Altamura, et al.
Psychiatry Research|March 16, 2013
Apathy, poor verbal memory and male gender predict lower psychosocial functioning one year after the first treatment of psychosisAnn Faerden, Elizabeth Ann Barrett, Ragnar Nesvåg, et al.
Archives of General Psychiatry|July 16, 2003
Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorderSteven G Potkin, Anutosh R Saha, Mary J Kujawa, et al.
Schizophrenia Bulletin|September 28, 2013
Adapting social neuroscience measures for schizophrenia clinical trials, Part 2: trolling the depths of psychometric propertiesRobert S Kern, David L Penn, Junghee Lee, et al.
Pageof 17